Introduction: why a supplement on taxanes?
Division of Hematology/Oncology, New York University (NYU) Cancer Institute, New York, New York, USA.
Franco M
FM
Muggia
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077143:Docetaxel; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000627:therapeutic use*; D043823:Taxoids / Q000627:therapeutic use
D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel; C552428:cabazitaxel; D017239:Paclitaxel